PLYMOUTH
MEETING, Pa., May 5, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company
focused on developing and commercializing DNA medicines to help
treat and protect people from HPV-related diseases, cancer, and
infectious diseases, today announced that Jacqueline Shea, Ph.D., President and CEO, will present at the 2023
RBC Capital Markets Global Healthcare Conference.
2023 RBC Capital Markets Global Healthcare
Conference
Date: Wednesday, May 17,
2023
Time: 4:05 PM ET
Format: Fireside Chat
During the conference, Dr. Shea and members of INOVIO's
management team will conduct one-on-one meetings with registered
investors.
A webcast of the presentation will be available on the INOVIO
Investor Relations Events page at
https://ir.inovio.com/events-and-presentations/default.aspx. A
replay of the webcast will be available for 90 days after the date
of the presentation.
About INOVIO
INOVIO is a biotechnology company focused on developing and
commercializing DNA medicines to help treat and protect people from
HPV-related diseases, cancer, and infectious diseases. INOVIO's DNA
medicines in development are delivered using its investigational
proprietary smart device, CELLECTRA®, to produce immune responses
against targeted pathogens and cancers. For more information, visit
www.inovio.com.
Contacts
Media: Jennie Willson (267)
429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267)
440-4298 thomas.hong@inovio.com
View original
content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-2023-rbc-capital-markets-global-healthcare-conference-301816542.html
SOURCE INOVIO Pharmaceuticals, Inc.